CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 30 enrolled
Drug / intervention
Voice Crisis Alert V2behavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03585543
NCT03585543N/ACompleted

Self-Management for Youth and Families Living With Sickle Cell Disease - SMYLS

Medical University of South Carolina·interventional·Posted Jul 13, 2018·Updated Nov 19, 2020

In Brief

A clinical study evaluating Voice Crisis Alert V2 for Sickle Cell Disease. Completed, enrolled 30 participants across 1 site.

Detailed Summary

The purpose of this proposal is to integrate family-centered self-management strategies with mobile health (mHealth) technology to improve reach, self-management behaviors, and child and caregiver physical and psychosocial symptoms and quality of life. Specifically, the investigators propose to conduct feasibility testing of SMYLS, which has been adapted based on user feedback in the first phase of this study. First the investigators will work with the Medical University of South Carolina (MUSC) Pediatric Sickle Cell Clinic to identify and recruit families with children with sickle cell disease (SCD) in the community, statewide. Next, the investigators will test the feasibility of the intervention with 30 dyads of children ages 8 - 17 with sickle cell disease and their parent or primary caregiver, (N=60)

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedJul 13, 2018
Enrollment StartMar 16, 2018
Primary CompletionJan 31, 2019
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 8.0 years ago

Interventions

Voice Crisis Alert V2behavioral

Intervention consists of a mHealth app delivered via smartphone